"A 1.3-million-square-foot, modern facility in Newark, Delaware, Christiana Hospital provides a level of care only available in large-scale teaching hospitals. Christiana Hospital includes Delaware’s only Level I trauma center."

During the past decade, Christiana Care Health System-Christiana Hospital conducted 213 clinical trials. In the 10-year time frame, 213 clinical trials started and 215 clinical trials were completed, i.e. on average, 100.9% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 121 clinical trials were completed. i.e. 177.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christiana Care Health System-Christiana Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 148 trials, followed by "Christiana Care Health Services" with 48 trials sponsored, "Alliance for Clinical Trials in Oncology" with 31 trials sponsored, "SWOG Cancer Research Network" with 29 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 29 trials sponsored. Other sponsors include 190 different institutions and companies that sponsored additional 106 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christiana Care Health System-Christiana Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 146 trials as a collaborator, "NRG Oncology" with 46 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator and "Radiation Therapy Oncology Group" with 7 trials as a collaborator. Other collaborators include 202 different institutions and companies that were collaborators in the rest 126 trials.

According to Clinical.Site data, the most researched conditions in "Christiana Care Health System-Christiana Hospital" are "Recurrent Ovarian Carcinoma" (14 trials), "Recurrent Fallopian Tube Carcinoma" (13 trials), "Recurrent Primary Peritoneal Carcinoma" (12 trials), "Fallopian Tube Transitional Cell Carcinoma" (11 trials) and "Recurrent Breast Carcinoma" (11 trials). Many other conditions were trialed in "Christiana Care Health System-Christiana Hospital" in a lesser frequency.

Most popular intervention types in "Christiana Care Health System-Christiana Hospital" are "Drug" (305 trials), "Other" (226 trials), "Biological" (112 trials), "Procedure" (72 trials) and "Radiation" (61 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (126 trials), "Quality-of-Life Assessment" (73 trials), "Paclitaxel" (50 trials), "Carboplatin" (40 trials) and "Questionnaire Administration" (39 trials). Other intervention names were less common.

The vast majority of trials in "Christiana Care Health System-Christiana Hospital" are 352 trials for "All" genders, 104 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are 199 active trials in "Christiana Care Health System-Christiana Hospital". 1 are not yet recruiting, 58 are recruiting, 139 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 209 completed trials in Christiana Care Health System-Christiana Hospital, 7 suspended trials, and 42 terminated clinical trials to date.

Out of the total trials that were conducted in Christiana Care Health System-Christiana Hospital, 19 "Phase 1" clinical trials were conducted, 177 "Phase 2" clinical trials and 183 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 63 trials that are defined as “Not Applicable".

Christiana Care Health System-Christiana Hospital has several departments that took part in Clinical trials: "Christiana Gynecologic Oncology LLC" - 81 trials, "Helen F Graham Cancer Center" - 269 trials, "Christiana Care/Helen F. Graham Cancer Center" - 6 trials